vai al contenuto della pagina vai al menu di navigazione
 

Archivio anno 2011

New molecular targets beyond KIT and PDGFRA in gastrointestinal stromal tumors: present and future
Expert Opin Ther Targets. 2011 Jul;15(7):803-15.
Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up
Med Oncol. 2012 Mar;29(1):144-50.
Molecular detection of epidermal growth factor receptor in colorectal cancer: does it still make sense?
Colorectal Dis 2011;13:542-8
Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports)
Oncol Rep. 2011 Jan;25(1):113-20.
Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor
Rare Tumors. 2011 Oct 21;3(4):e49.
Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours
Histopathology. 2011 Dec;59(6):1071-80.
When should F-18 FDG PET/CT be used instead of 68Ga-DOTA-peptides to investigate metastatic neuroendocrine tumors?
Clin Nucl Med. 2011 Dec;36(12):1109-11.
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations.
Am J Surg Pathol. 2011 Nov;35(11):1750-2.
The follow-up after radical surgery of colorectal cancer: is it time for a "tailored" strategy?
Clin Colorectal Cancer. 2011 Jun;10(2):81-4.
Three cases of bone metastases in patients with gastrointestinal stromal tumors
Rare Tumors. 2011 Apr 4;3(2):e17.
The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting
J Transl Med. 2011 May 23;9:75.
SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing
J Natl Cancer Inst. 2011 Jun 22;103(12):983-7.
New molecular targets beyond KIT and PDGFRA in gastrointestinal stromal tumors: present and future
Expert Opin Ther Targets. 2011 Jul;15(7):803-15.